Clinical trial
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
NCT00088452 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00088452 |
|---|---|
| Title | Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study |
| Official title | Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Childhood Absence Epilepsy, Petit Mal Epilepsy, Epilepsy, Seizures |
| Intervention type | Drug |
| Interventions | Ethosuximide, Lamotrigine, Valproic acid |
| Enrollment | 453 |
| Start date | Jul 1, 2004 |
| Primary completion | Jan 1, 2013 |
| Completion | Aug 31, 2016 |
| First posted | Jul 27, 2004 |
| Last update posted | Oct 14, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: